Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NAFLD (Non-Alcoholic Fatty Liver Disease)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01617772
What this trial is testing

Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis

Who this might be right for
Non-alcoholic Steatohepatitis
Tehran University of Medical Sciences 440
Not applicableStudy completedNCT04988230
What this trial is testing

Time Restricted Feeding on Nonalcoholic Fatty Liver Disease ( TREATY-FLD )：a 12-month Follow-up Study

Who this might be right for
Nonalcoholic Fatty Liver Disease
Nanfang Hospital, Southern Medical University 88
Not applicableStudy completedNCT02083367
What this trial is testing

Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome

Who this might be right for
Hepatic EncephalopathyCirrhosisNonalcoholic Steatohepatitis+1 more
OSF Healthcare System 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07310407
What this trial is testing

Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Who this might be right for
NAFLD
Ain Shams University 120
Large-scale testing (Phase 3)Study completedNCT05768334
What this trial is testing

Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLD
Helwan University 116
Not applicableLooking for participantsNCT04442334
What this trial is testing

The European NAFLD Registry

Who this might be right for
NAFLDNASHNASH - Nonalcoholic Steatohepatitis+9 more
Newcastle University 10,000
Testing effectiveness (Phase 2)Study completedNCT06482112
What this trial is testing

Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNon-alcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver Disease+1 more
Merck Sharp & Dohme LLC 124
Large-scale testing (Phase 3)Looking for participantsNCT07165028
What this trial is testing

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company 4,500
Not applicableStudy completedNCT02363309
What this trial is testing

Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Fatty Liver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 74
Not applicableStudy completedNCT05092399
What this trial is testing

Effects of VLCD and Bariatric Surgery in Patients With Type 2 Diabetes

Who this might be right for
Type2 DiabetesNAFLDObesity
University of Nottingham 21
Not applicableLooking for participantsNCT06814600
What this trial is testing

Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients

Who this might be right for
NAFLDInflammatory Bowel DiseasesSteatosis+1 more
Centre Hospitalier Universitaire Saint Pierre 150
Testing effectiveness (Phase 2)Study completedNCT00501592
What this trial is testing

Study of INT-747 in Patients With Diabetes and Presumed NAFLD

Who this might be right for
Diabetes Mellitus, Type IIFatty Liver
Intercept Pharmaceuticals 64
Not applicableUnknownNCT05359471
What this trial is testing

Characterization of Visceral Adiposity in HIV Mono-infected Patients With NAFLD

Who this might be right for
Visceral SteatosisHivNAFLD
McGill University Health Centre/Research Institute of the McGill University Health Centre 30
Post-approval studies (Phase 4)Study completedNCT03068065
What this trial is testing

Antidiabetic Effects on Intrahepatic Fat

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseType2 Diabetes
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 87
Not applicableActive Not RecruitingNCT05479721
What this trial is testing

LITMUS Imaging Study

Who this might be right for
NAFLDNASHNASH - Nonalcoholic Steatohepatitis+2 more
University of Oxford 450
Very early researchStudy completedNCT05737433
What this trial is testing

Single Dose ADME Study of [14C]-Rencofilstat in Healthy Male Subjects

Who this might be right for
NASH With Fibrosis
Hepion Pharmaceuticals, Inc. 6
Not applicableStudy completedNCT03897218
What this trial is testing

Dietary Modulation of Intestinal Microbiota as Trigger of Liver Health: Role of Bile Acids - "A Diet for Liver Health"

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
RWTH Aachen University 84
Not applicableEnded earlyNCT00283374
What this trial is testing

Study Evaluating Metabolic Syndrome in Subjects Undergoing Gastric Bypass Bariatric Syndrome

Who this might be right for
Morbid ObesityMetabolic Disease
Wyeth is now a wholly owned subsidiary of Pfizer 120
Not applicableUnknownNCT05643521
What this trial is testing

The Acute Effects of Eucaloric and Hypocaloric Carbohydrate Restriction on Liver Fat Content and Metabolism in Obese Individuals

Who this might be right for
NAFLDOverweight and ObesityMetabolic Syndrome+1 more
Hvidovre University Hospital 14
Not applicableUnknownNCT05076058
What this trial is testing

Effects of Tablets of Silybum Marianum, Pueraria Lobate and Salvia Miltiorrhiza on Fatty Liver

Who this might be right for
Fatty Liver Disease
Sun Yat-sen University 118
Next Page